证券之星消息，3月5日南向资金减持9.41万股阿里健康（00241.HK）。近5个交易日中，获南向资金增 持的有2天，累计净增持306.78万股。近20个交易日中，获南向资金增持的有14天，累计净增持2357.63 万股。截至目前，南向资金持有阿里健康（00241.HK）19.89亿股，占公司已发行普通股的12.29%。 阿里健康信息技术有限公司是一家为医疗医药行业提供产业互联网解决方案的投资控股公司，是阿里巴 巴控股在大健康领域的旗舰平台。该公司主要从事发展医药健康产品销售业务，营运医药电商平台及消 费医疗服务平台，通过云计算、大数据等技术发展追溯及数字医疗及互联网医疗业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

阿里健康信息技术有限公司是一家为医疗医药行业提供产业互联网解决方案的投资控股公司，是阿里巴 巴控股在大健康领域的旗舰平台。该公司主要从事发展医药健康产品销售业务，营运医药电商平台及消 费医疗服务平台，通过云计算、大数据等技术发展追溯及数字医疗及互联网医疗业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，3月4日南向资金增持224.83万股阿里健康（00241.HK）。近5个交易日中，获南向资金 增持的有3天，累计净增持367.94万股。近20个交易日中，获南向资金增持的有14天，累计净增持 2268.84万股。截至目前，南向资金持有阿里健康（00241.HK）19.89亿股，占公司已发行普通股的 12.29%。 ...

Core Viewpoint - Southbound funds have increased their holdings in Alibaba Health (00241.HK) significantly, indicating growing investor confidence in the company [1] Group 1: Investment Activity - On February 23, southbound funds increased their holdings by 6.5 million shares of Alibaba Health [1] - Over the past 5 trading days, there have been 4 days of net increases in holdings, totaling 20.14 million shares [1] - In the last 20 trading days, there were 14 days of net increases, amounting to 20.54 million shares [1] - Currently, southbound funds hold 1.985 billion shares of Alibaba Health, representing 12.27% of the company's total issued ordinary shares [1] Group 2: Company Overview - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the medical and pharmaceutical industry [1] - The company is the flagship platform of Alibaba Group in the health sector, focusing on the development of pharmaceutical health product sales [1] - It operates a pharmaceutical e-commerce platform and consumer healthcare service platform, utilizing cloud computing and big data for traceability and digital healthcare [1]

Group 1 - The core point of the article highlights that southbound funds increased their holdings in Alibaba Health (00241.HK) by 11.662 million shares on February 9 [1] - Over the past five trading days, there were two days of net reductions in holdings by southbound funds, totaling a net decrease of 15.941 million shares [1] - In the last 20 trading days, there were 13 days of net increases in holdings by southbound funds, with a total net increase of 191 million shares [1] Group 2 - As of now, southbound funds hold 1.957 billion shares of Alibaba Health (00241.HK), accounting for 12.08% of the company's total issued ordinary shares [1] - Alibaba Health Information Technology Co., Ltd. is a holding company providing industrial internet solutions for the medical and pharmaceutical industry, serving as Alibaba Group's flagship platform in the health sector [1] - The company primarily engages in the sales of pharmaceutical health products, operates a pharmaceutical e-commerce platform, and offers consumer healthcare services, utilizing technologies such as cloud computing and big data for traceability and digital healthcare [1]

Group 1 - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 4.238 million shares on February 6 [1] - Over the past 5 trading days, there were 2 days of net reductions in holdings by southbound funds, totaling a net decrease of 26.959 million shares [1] - In the last 20 trading days, there were 13 days of net increases in holdings by southbound funds, with a total net increase of 181 million shares [1] Group 2 - As of now, southbound funds hold 1.945 billion shares of Alibaba Health, accounting for 12.02% of the company's total issued ordinary shares [1] - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the medical and pharmaceutical industry and is Alibaba Group's flagship platform in the health sector [1] - The company primarily engages in the sales of pharmaceutical health products, operates a pharmaceutical e-commerce platform, and offers consumer medical services, utilizing cloud computing and big data technologies for traceability and digital healthcare [1]

Group 1 - The core viewpoint of the news is that Langma Information (300288) has experienced a decline in its financial performance, with significant drops in revenue and net profit for the first three quarters of 2025 compared to the previous year [2] - As of February 3, 2026, Langma Information's stock closed at 14.57 yuan, up 2.17%, with a turnover rate of 3.88% and a trading volume of 99,500 hands, resulting in a transaction amount of 143 million yuan [1] - The net outflow of main funds on February 3 was 2.0659 million yuan, accounting for 1.44% of the total transaction amount, while retail investors saw a net inflow of 7.6134 million yuan, representing 5.31% of the total transaction amount [1] Group 2 - For the first three quarters of 2025, Langma Information reported a main operating income of 224 million yuan, a year-on-year decrease of 24.75%, and a net profit attributable to shareholders of 13.507 million yuan, down 67.04% year-on-year [2] - In the third quarter of 2025 alone, the company recorded a single-quarter main operating income of 72.5269 million yuan, a decline of 36.46% year-on-year, and a net profit attributable to shareholders of -0.9285 million yuan, reflecting a decrease of 105.48% year-on-year [2] - The company's debt ratio stands at 17.27%, with investment income of 16.9959 million yuan and a gross profit margin of 29.25% [2]

Core Viewpoint - Southbound funds have significantly increased their holdings in Alibaba Health, indicating strong investor interest and confidence in the company's future prospects [1] Group 1: Investment Activity - On January 15, southbound funds increased their holdings by 6.0196 million shares of Alibaba Health (00241.HK) [1] - Over the past 5 trading days, there has been a cumulative net increase of 86.556 million shares, with increases recorded on all 5 days [1] - In the last 20 trading days, there were 13 days of net increases, totaling 12.1306 million shares [1] - Currently, southbound funds hold 1.843 billion shares of Alibaba Health, representing 11.38% of the company's total issued ordinary shares [1] Group 2: Company Overview - Alibaba Health Information Technology Co., Ltd. is a holding company providing industrial internet solutions for the healthcare and pharmaceutical industry [1] - The company primarily engages in the sales of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [1] - It leverages technologies such as cloud computing and big data to develop traceability, digital healthcare, and internet medical services [1]

Core Viewpoint - The stock of Langma Information (300288) has shown a stable closing price with minor fluctuations, indicating a mixed sentiment among investors as reflected in the recent capital flow data [1][2]. Group 1: Stock Performance - As of December 12, 2025, Langma Information closed at 13.48 yuan, with no change in price [1]. - The trading volume was 33,700 hands, with a total transaction amount of 45.59 million yuan [1]. - The capital flow data indicates a net inflow of 663,900 yuan from institutional investors, accounting for 1.46% of the total transaction amount [1][2]. Group 2: Recent Capital Flow Trends - Over the past five days, the stock has experienced significant fluctuations in capital flow, with a notable net outflow from retail investors on December 11, amounting to 13.41 million yuan [2]. - The net inflow from retail investors on December 12 was 1.60 million yuan, representing 3.51% of the total transaction amount [1][2]. Group 3: Financial Metrics and Industry Comparison - Langma Information's total market capitalization is 4.555 billion yuan, significantly lower than the industry average of 13.319 billion yuan [3]. - The company reported a net profit of 13.507 million yuan for the first three quarters of 2025, a decline of 67.04% year-on-year [3]. - The company's gross profit margin stands at 29.25%, slightly below the industry average of 31.3% [3].

Core Viewpoint - The stock of Langma Information (300288) has shown a decline in both price and trading volume, with significant net outflows from major and retail investors, indicating a bearish sentiment in the market [1][2]. Financial Performance - As of November 28, 2025, Langma Information's stock closed at 14.68 yuan, down 0.27%, with a trading volume of 63,700 hands and a total transaction amount of 93.32 million yuan [1]. - In the last five days, the stock has experienced a downward trend, with a total net outflow of 2.73 million yuan from major investors and 314.73 thousand yuan from retail investors on November 28 [2]. - The company's Q3 2025 report indicates a significant decline in revenue, with a year-on-year decrease of 24.75% to 22.4 million yuan and a net profit drop of 67.04% to 13.51 million yuan [3]. Market Position - Langma Information's total market capitalization is 4.961 billion yuan, which is below the industry average of 13.725 billion yuan, ranking 105 out of 145 in the internet services sector [3]. - The company's price-to-earnings ratio (P/E) stands at 275.47, significantly higher than the industry average of 130.58, indicating potential overvaluation [3]. - The gross margin of Langma Information is 29.25%, slightly below the industry average of 31.3%, while the net margin is 4.91%, which is better than the industry average of -5.07% [3].

Group 1 - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 3.354 million shares on November 26, 2025, marking a 0.19% change [1][2] - Over the past five trading days, southbound funds have increased their holdings for four days, with a total net increase of 6.738 million shares [1] - In the last 20 trading days, there have been 13 days of net increases, totaling 44.136 million shares [1] Group 2 - As of now, southbound funds hold 1.784 billion shares of Alibaba Health, accounting for 11.02% of the company's total issued ordinary shares [1] - The company primarily engages in the sale of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [2] - Alibaba Health is a flagship platform for Alibaba Group in the health sector, utilizing cloud computing and big data technologies for digital healthcare and internet medical services [2]